Dow Jones

38,711.29

0.36%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Synergy Pharmaceuticals, Inc. (SGYP)
Synergy Pharmaceuticals, Inc. (SGYP) Noticias

SGYP

Synergy Pharmaceuticals, Inc. (SGYP)

Synergy Pharmaceuticals, Inc.

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SGYP

1 2 3 4 5 6 7 8 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
01/12/2021	01:00	GlobeNewswire Inc.	OKYO Pharma Limited: Directorate Change	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
02/05/2019	09:58	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
02/05/2019	09:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
06/03/2019	08:30	PR Newswire (US)	Synergy Pharmaceuticals Announces Completion of Sale to Bausch Health	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
06/03/2019	08:00	PR Newswire (Canada)	Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
01/03/2019	18:13	Dow Jones News	Synergy Pharmaceuticals Is Approved to Sell Assets to Bausch Health	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
01/03/2019	17:30	PR Newswire (US)	Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
26/02/2019	18:07	Dow Jones News	Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
26/02/2019	17:00	PR Newswire (US)	Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
12/02/2019	11:53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
17/12/2018	14:43	Dow Jones News	Synergy Pharmaceuticals Up 55% on Trulance Progress in Canada	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
12/12/2018	10:10	Dow Jones News	Former Pharma Highflier Appreciates Bathroom Humor -- Overheard	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
12/12/2018	07:18	Dow Jones News	Bausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--Update	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
12/12/2018	06:14	Dow Jones News	Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
12/12/2018	05:30	PR Newswire (US)	Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceut...	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
12/12/2018	05:00	PR Newswire (US)	Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
15/11/2018	11:33	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
09/11/2018	08:09	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
08/11/2018	16:00	Business Wire	Synergy Pharmaceuticals Reports Third Quarter 2018 Financial Results and Business Update	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
31/10/2018	16:00	Business Wire	Synergy Pharmaceuticals Names Dr. Melvin K. Spigelman Chairman	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
25/10/2018	16:00	Business Wire	Synergy Pharmaceuticals Provides Business Update	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
08/10/2018	07:00	Business Wire	Synergy Pharmaceuticals Presents New Analyses Supporting the Use of TRULANCE® (plecanatide) in Two Patient Populations at th...	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
01/10/2018	08:30	Business Wire	Synergy Pharmaceuticals to Present New Analyses of TRULANCE® (Plecanatide) at the American College of Gastroenterology (ACG)...	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
24/09/2018	07:00	Business Wire	Synergy Pharmaceuticals Strengthens Coverage for TRULANCE® (plecanatide) with Key New Market Access Wins	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
16/08/2018	16:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
07/08/2018	20:22	Business Wire	CORRECTING and REPLACING Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business Update	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
07/08/2018	16:00	Business Wire	Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business Update	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
07/08/2018	08:00	Business Wire	Synergy Pharmaceuticals Announces TRULANCE® (plecanatide) Added to Express Scripts 2019 National Preferred Formulary List	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
07/08/2018	05:00	Business Wire	Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in China	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.
13/06/2018	06:30	Business Wire	Synergy Pharmaceuticals Announces Amendment to CRG Debt Agreement	NASDAQ:SGYP	Synergy Pharmaceuticals, Inc.